Clinical evidence on traditional HF therapies with treatments such as beta-blockade, mineralocorticoid receptor antagonists (MRA), and renin-angiotensin-aldosterone inhibition (RAASi) in ATTR-CM is limited. Here, REN is linked to hydrops fetalis.